Ishita Drugs and Industries Limited (BOM:524400)

India · Delayed Price · Currency is INR

76.54

+0.54 (0.71%)

At close: Aug 21, 2026

3.32% (1Y)

Market Cap	228.88M +3.3%
Revenue (ttm)	124.05M -28.6%
Net Income	7.06M -30.9%
EPS	2.36
Shares Out	2.99M
PE Ratio	32.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	363
Open	76.38
Previous Close	76.00
Day's Range	76.38 - 76.60
52-Week Range	66.00 - 90.85
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 8, 2026

About BOM:524400

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in A... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1992

Employees 14

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524400

Full Company Profile

Financial Performance

In fiscal year 2026, BOM:524400's revenue was 146.60 million, a decrease of -2.25% compared to the previous year's 149.97 million. Earnings were 7.79 million, a decrease of -10.32%.

Financial Statements